Brooks Life Sciences supports and advances the research, pre-clinical and clinical scientific community with its highly-flexible and fully comprehensive sample management storage solutions, instruments, devices and consumables.

Our customers experience best-in-class solutions for automated storage systems for compounds and biospecimens, biorepository and biobanking services, pre-clinical and clinical sample storage consumables and instruments, cell therapy cryopreservation and cold chain solutions, to global sample preparation and analytical lab services.


Solutions to manage samples across the research continuum for:

Featured Content

Dr. Ko Webinar

Dr. Jennifer Ko Webinar - Expanding Biobanking Size and Scope to Advance Big Data Discovery

Learn about how Cleveland Clinic is partnering with Brooks Life Sciences and embarking on an enterprise-wide initiative to accelerate its biobanking capacity, leveraging its clinical volume and disease expertise and building a state of the art, 21,000 square-foot structure biobanking facility.

Hear more about what clinical translational specimens we have that could contribute to big data discovery and what resources are needed to build an infrastructure to enhance researchers' study of human tissue samples and advance personalized medicine for an array of conditions.

Listen Now!

Upcoming Events

March 11, 2019 — March 12, 2019

SLAS 2019 European Sample Management Symposium

9:00 AM Conferences

The 2019 SLAS European Sample Management Symposium welcomes all compound and sample management professionals – from bench scientists to senior leaders – to obtain fresh perspectives and share innovative solutions to challenges in these domains.


March 21, 2019 — March 23, 2019


9:00 AM Conferences

The 18th Congress of the Japanese Society for Regenerative Medicine (18JSRM).

March 25, 2019 — March 27, 2019

Bio-Europe Spring 2019

7:45 AM Conferences

Ignite powerful partnerships with life science leaders. This year’s event in Vienna will bring together the “who’s who” from the biotech, pharma and finance industry, allowing delegates to meet more key decision makers in three days of partnering meetings than they could in a whole year.